Cited by 289Iron Metabolism and DisordersMetal complexes synthesis and propertiesInorganic and Organometallic Chemistry

The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.

Design of iron chelators with therapeutic application

Liu, Zu D, Hider, Robert C·2002·Coordination Chemistry Reviews

DOI 10.1016/s0010-8545(02)00050-4

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0010-8545(02)00050-4

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Critical Stability Constants
Martell, A. E., & Smith, R. M. (1982) · Springer eBooks · doi:10.1007/978-1-4615-6761-5 · Cited by 6,025
Free Radicals in Biology and Medicine
Land, E. J. (1990) · International Journal of Radiation Biology · doi:10.1080/09553009014552071 · Cited by 4,871
Disorders of Iron Metabolism
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,862
Undetectable Intracellular Free Copper: The Requirement of a Copper Chaperone for Superoxide Dismutase
Rae, T., Schmidt, P. J., Pufahl, R. A., Culotta, V., & O’Halloran, T. V. (1999) · Science · doi:10.1126/science.284.5415.805 · Cited by 1,640
Principles of bioinorganic chemistry
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4515 · Cited by 1,538
Principles of bioinorganic chemistry
Chayen, J. (1995) · Cell Biochemistry and Function · doi:10.1002/cbf.290130214 · Cited by 1,060
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
Levin, V. A. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00180a022 · Cited by 817

Show all 132 references

Research works printed but not linked: 27

Pearson, 1963, J. Am. Chem. Soc., 85, 3535
Grady, 1976, J. Pharmacol. Exp. Ther., 196, 478
Winston, 1985, J. Pharmacol. Exp. Ther., 232, 644
Tilbrook, 1998, 35, 691
Holander, 1988, Can. J. Gastroenterol., 2, 35A
Yokel, 1995, Drug Metab. Dispos., 23, 1178
Hider, 1999, Blood, 94, 406A
Hider, 1992, Proc. R. Soc. Edinburgh, 99B, 137
Hershko, 1978, J. Lab. Clin. Med., 92, 144
Pippard, 1978, Clin. Sci. Mol. Med., 54, 99
Freedman, 1990, Am. J. Dis. Child, 144, 565
Lau, 1983, J. Lab. Clin. Med., 101, 806
R. Lattmann, P. Acklin, P. Buhlmayer, A. Crowe, B. Faller, Y. Jin, D. Ledergerber, H.P. Nick, T. Sergejew, C. Spanka, A. Wong, P. Zbinden, H.P. Schnebli, 11th International Conference on Oral Chelation in the Treatment of Thalassaemia, Catania, Italy, 22–25 March 2001, p. 89.
Hershko, 1981, J. Lab. Clin. Med., 98, 99
Johnson, 1982, J. Pharmacol. Exp. Ther., 221, 399
Brittenham, 1990, Semin. Hematol., 27, 112
Webb, 1988, Birth Defects Original Article Ser., 23, 63
Wolfe, 1990, Sem. Haematol., 27, 117
Singh, 1992, Drug Metab. Dispos., 20, 256
Maggio, 1999, Blood, 94, 34B
Cohen, 1999, Blood, 94, 406A
Lu, 2000, Drug Metab. Dispos., 28, 873
Liu, 2000, Arzneim-Forsch/Drug Res., 50, 461
Choudhury, 1997, Drug Metab. Dispos., 25, 332
P. Zbinden, US Patent 5,688,815 (1997).
Hider, 1992, Proc. R. Soc. Edinburgh, 99B, 137
Hoyes, 1992, Cancer Res., 52, 4591

Sorted by citations

Application of Metal Coordination Chemistry To Explore and Manipulate Cell Biology
Haas, K. L., & Franz, K. J. (2009) · Chemical Reviews · doi:10.1021/cr900134a · Cited by 1,003
New metal complexes as potential therapeutics
Zhang, C. X., & Lippard, S. J. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00081-4 · Cited by 947
Iron(iii) selective molecular and supramolecular fluorescent probes
Sahoo, S. K., Sharma, D., Bera, R. K., Crisponi, G., & Callan, J. F. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35152h · Cited by 775
Bioinorganic Photochemistry: Frontiers and Mechanisms
Szacilowski, K. T., Macyk, W., Drzewiecka‐Matuszek, A., Brindell, M., & Stochel, G. (2005) · Chemical Reviews · doi:10.1021/cr030707e · Cited by 731
The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer
Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.2 · Cited by 721
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411
Self-citation
Recent developments in penta-, hexa- and heptadentate Schiff base ligands and their metal complexes
Liu, X., & Hamon, J. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.03.010 · Cited by 391
Oxidative Stress and Iron Homeostasis: Mechanistic and Health Aspects
Galaris, D., & Pantopoulos, K. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701713104 · Cited by 352
Traversing the coordination chemistry and chemical biology of hydroxamic acids
Codd, R. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.08.001 · Cited by 292
Copper-related diseases: From chemistry to molecular pathology
Crisponi, G., Nurchi, V. M., Fanni, D., Gerosa, C., Nemolato, S., & Faa, G. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.12.018 · Cited by 252
Antioxidant actions of flavonoids: Thermodynamic and kinetic analysis
Galleano, M., Verstraeten, S. V., Oteiza, P. I., & Fraga, C. G. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.04.005 · Cited by 257
Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity
Jansson, P. J., Sharpe, P. C., Bernhardt, P. V., & Richardson, D. R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100561b · Cited by 250
Metals ions and neurodegeneration
Molina‐Holgado, F., Hider, R. C., Gaeta, A., Williams, R., & Francis, P. T. (2007) · BioMetals · doi:10.1007/s10534-006-9033-z · Cited by 206
Self-citation
Hydroxamic Acids − An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands
Marmion, C. J., Griffith, D. M., & Nolan, K. B. (2004) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200400221 · Cited by 182
Formation of fluorescent polydopamine dots from hydroxyl radical-induced degradation of polydopamine nanoparticles
Lin, J., Yu, C., Yang, Y.-C., & Tseng, W. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp00932d · Cited by 179
A review of metal‐catalyzed molecular damage: protection by melatonin
Romero, A., Ramos, E., Rı́os, C. D. L., Egea, J., del Pino, J., & Reiter, R. J. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12132 · Cited by 176
Complex Formation of ICL670 and Related Ligands with FeIII and FeII
Steinhauser, S., Heinz, U., Bartholomä, M. D., Weyhermüller, T., Nick, H., & Hegetschweiler, Κ. (2004) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200400363 · Cited by 177
Anticancer metal compounds in NCI's tumor-screening database: putative mode of action
Huang, R., Wallqvist, A., & Covell, D. G. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.001 · Cited by 171
Iron chelating agents for the treatment of iron overload
Crisponi, G., & Remelli, M. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.12.014 · Cited by 167
Effective Treatment of Manganese-Induced Occupational Parkinsonism With p-Aminosalicylic Acid: A Case of 17-Year Follow-Up Study
Jiang, Y., Mo, X., Feng-qi, D., Fu, X., Zhu, X., Gao, H.-Y., Xie, J., Liao, F.-L., Pira, E., & Zheng, W. (2006) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000204114.01893.3e · Cited by 157
Minding metals: Tailoring multifunctional chelating agents for neurodegenerative disease
Perez, L. R., & Franz, K. J. (2010) · Dalton Trans. · doi:10.1039/b919237a · Cited by 156
Evidence for a Common Non‐Heme Chelatable‐Iron‐Dependent Activation Mechanism for Semisynthetic and Synthetic Endoperoxide Antimalarial Drugs
Stocks, P. A., Bray, P. G., Barton, V., Al‐Helal, M., Jones, M., Araújo, N., Gibbons, P. D., Ward, S. A., Hughes, R. H., Biagini, G. A., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604697 · Cited by 140
Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action
Shakya, B., & Yadav, P. N. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666191029130310 · Cited by 140
Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs
Santos, M. A., Marques, S. M., & Chaves, S. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.08.008 · Cited by 131
On the preferences of five-membered chelate rings in coordination chemistry: insights from the Cambridge Structural Database and theoretical calculations
Bazargan, M., Mirzaei, M., Franconetti, A., & Frontera, A. (2019) · Dalton Transactions · doi:10.1039/c9dt00542k · Cited by 127
Review: recent advances and future development of metal complexes as anticancer agents
Jia, P., Ouyang, R., Cao, P., Tong, X., Zhou, X., Lei, T., Zhao, Y., Guo, N., Chang, H., Miao, Y., et al. (2017) · Journal of Coordination Chemistry · doi:10.1080/00958972.2017.1349313 · Cited by 126
Metal Complexes as Drugs and Chemotherapeutic Agents
Farrell, N. P. (2003) · Elsevier eBooks · doi:10.1016/b0-08-043748-6/09021-6 · Cited by 109
Iron sequestration by small molecules: Thermodynamic and kinetic studies of natural siderophores and synthetic model compounds
Crumbliss, A. L., & Harrington, J. M. (2009) · Advances in inorganic chemistry · doi:10.1016/s0898-8838(09)00204-9 · Cited by 108
Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone
Nurchi, V. M., Crisponi, G., Pivetta, T., Donatoni, M., & Remelli, M. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.10.012 · Cited by 106
Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles
Bardestani, A., Ebrahimpour, S., Esmaeili, A., & Esmaeili, A. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01059-0 · Cited by 106
Complexation of iron(III) by catecholate-type polyphenols
Elhabiri, M., Carrër, C., Marmolle, F., & Traboulsi, H. (2006) · Inorganica Chimica Acta · doi:10.1016/j.ica.2006.07.110 · Cited by 99
In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators
Rossi, N. A. A., Mustafa, I., Jackson, J. K., Burt, H. M., Horte, S. A., Scott, M. D., & Kizhakkedathu, J. N. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.057 · Cited by 97
Siderophores as molecular tools in medical and environmental applications
Kurth, C., Kage, H., & Nett, M. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01400c · Cited by 101
Metal trafficking: from maintaining the metal homeostasis to future drug design
Ba, L. A., Doering, M., Burkholz, T., & Jacob, C. (2009) · Metallomics · doi:10.1039/b904533c · Cited by 98
Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, Aβ 1–42 aggregation inhibitors and metal-chelating agents for Alzheimer's disease
Xu, P., Zhang, M., Sheng, R., & Ma, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.045 · Cited by 92
Advances in iron chelation: an update
Heli, H., Mirtorabi, S., & Karimian, K. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.569493 · Cited by 92
Hydroxypyridinone Journey into Metal Chelation
Cilibrizzi, A., Abbate, V., Chen, Y., Ma, Y., Zhou, T., & Hider, R. C. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00254 · Cited by 90
Self-citation
Crystallographic, Photophysical, NMR Spectroscopic and Reactivity Manifestations of the “8-Heteroaryl Effect” in 4,4-Difluoro-8-(C4H3X)-4-bora-3a,4a-diaza-s-indacene (X = O, S, Se) (BODIPY) Systems
Kim, K., Jo, C., Easwaramoorthi, S., Sung, J., Kim, D. H., & Churchill, D. G. (2010) · Inorganic Chemistry · doi:10.1021/ic902467h · Cited by 86
Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues
Bernhardt, P. V., Caldwell, L. M., Chaston, T. B., Chin, P., & Richardson, D. R. (2003) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-003-0486-z · Cited by 84
Interaction of vanadium(IV) with human serum apo-transferrin
Mehtab, S., Gonçalves, G., Roy, S., Tomaz, A. I., Santos‐Silva, T., Santos, M. F. A., Romão, M. J., Jakusch, T., Kiss, T., & Pessoa, J. C. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.12.020 · Cited by 79
Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
Mounsey, R. B., & Teismann, P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/983245 · Cited by 83
Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity
Puerta, D. T., Griffin, M. O., Lewis, J. A., Romero‐Perez, D., Garcia, R. A., Villarreal, F. J., & Cohen, S. M. (2005) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-005-0053-x · Cited by 78
Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts
Musonda, C. C., Taylor, D., Lehman, J., Gut, J., Rosenthal, P. J., & Chibale, K. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.05.063 · Cited by 76
Vanadium compounds as therapeutic agents: Some chemical and biochemical studies
Faneca, H., Figueiredo, V. A., Tomaz, A. I., Gonçalves, G., Avecilla, F., de Lima, M. C. P., Geraldes, C. F. G. C., Pessoa, J. C., & Castro, M. M. C. A. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.11.004 · Cited by 75
The ferric enterobactin transporter Fep is required for persistent Salmonella enterica serovar Typhimurium infection
Nagy, T. A., Moreland, S. M., Andrews-Polymenis, H., & Detweiler, C. S. (2013) · Infection and Immunity · doi:10.1128/iai.00412-13 · Cited by 72
Predicting the Thermodynamic Stability of Zirconium Radiotracers
Holland, J. P. (2020) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b03515 · Cited by 70
Efficient Iron and ROS Nanoscavengers for Brain Protection after Intracerebral Hemorrhage
Zhu, F., Zi, L., Yang, P., Yang, W., Zhong, R., Wang, Y., You, C., Li, Y., Tian, M., & Gu, Z. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00491 · Cited by 68
Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
Cusnir, R., Imberti, C., Hider, R. C., Blower, P. J., & Ma, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010116 · Cited by 70
Self-citation
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: A comparison with desferrioxamine
Gharagozloo, M., Khoshdel, Z., & Amirghofran, Z. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.059 · Cited by 67
Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities
Bertrand, S., Hélesbeux, J., Larcher, G., & Duval, O. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/13895575113139990007 · Cited by 66
Review—Multifunctional Materials for Enhanced Li-Ion Batteries Durability: A Brief Review of Practical Options
Banerjee, A., Shilina, Y. A., Ziv, B., Ziegelbauer, J. M., Luski, S., Aurbach, D., & Halalay, I. C. (2017) · Journal of The Electrochemical Society · doi:10.1149/2.0451701jes · Cited by 66
Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets
Schneidewind, T., Brause, A., Pahl, A., Burhop, A., Mejuch, T., Sievers, S., Waldmann, H., & Ziegler, S. (2020) · ChemBioChem · doi:10.1002/cbic.202000381 · Cited by 65
Biocompatible Infinite‐Coordination‐Polymer Nanoparticle–Nucleic‐Acid Conjugates for Antisense Gene Regulation
Calabrese, C. M., Merkel, T. J., Briley, W. E., Randeria, P. S., Narayan, S. P., Rouge, J. L., Walker, D., Scott, A. W., & Mirkin, C. A. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407946 · Cited by 65
The Design of Orally Active Iron Chelators
HIDER, R. C., & ZHOU, T. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.017 · Cited by 64
Self-citation
Ten Years Progress of Electrical Detection of Heavy Metal Ions (HMIs) Using Various Field-Effect Transistor (FET) Nanosensors: A Review
Falina, S., Syamsul, M., Rhaffor, N. A., Hamid, S. S., Zain, K. A. M., Manaf, A. A., & Kawarada, H. (2021) · Biosensors · doi:10.3390/bios11120478 · Cited by 64
Synthesis and biological activity evaluation of hydrazone derivatives based on a Tröger’s base skeleton
Kaplánek, R., Havlík, M., Dolenský, B., Rak, J., Džubák, P., Konečný, P., Hajdúch, M., Králová, J., & Král, V. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.029 · Cited by 61
New insights on vanadium binding to human serum transferrin
Pessoa, J. C., Gonçalves, G., Roy, S., Correia, I., Mehtab, S., Santos, M. F. A., & Santos‐Silva, T. (2013) · Inorganica Chimica Acta · doi:10.1016/j.ica.2013.11.025 · Cited by 59
Caffeine–hydrazones as anticancer agents with pronounced selectivity toward T-lymphoblastic leukaemia cells
Kaplánek, R., Jakubek, M., Rak, J., Kejík, Z., Havlík, M., Dolenský, B., Frydrych, I., Hajdúch, M., Kolář, M., Bogdanová, K., et al. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.03.003 · Cited by 57
Addressing selectivity criteria in binding equilibria
Bazzicalupi, C., Bianchi, A., Giorgi, C., Clares, M. P., & García‐España, E. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.05.013 · Cited by 55
Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities
Jiang, X., Zhou, T., Bai, R., & Xie, Y. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01480 · Cited by 55
Modifications of boronic ester pro-chelators triggered by hydrogen peroxide tune reactivity to inhibit metal-promoted oxidative stress
Charkoudian, L. K., Pham, D. M., Kwon, A. M., Vangeloff, A. D., & Franz, K. J. (2007) · Dalton Transactions · doi:10.1039/b705199a · Cited by 53
Inositol hexa phosphoric acid (phytic acid), a nutraceuticals, attenuates iron-induced oxidative stress and alleviates liver injury in iron overloaded mice
Bhowmik, A., Ojha, D., Goswami, D., Das, R., Chandra, N. S., Chatterjee, T. K., Chakravarty, A., Chakravarty, S., & Chattopadhyay, D. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.125 · Cited by 53
Polymeric nanocarriers for the treatment of systemic iron overload
Hamilton, J. L., & Kizhakkedathu, J. N. (2015) · Molecular and Cellular Therapies · doi:10.1186/s40591-015-0039-1 · Cited by 51
New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways
Atto, B., Eapen, M. S., Sharma, P. K., Frey, U., Ammit, A. J., Markos, J., Chia, C., Larby, J., Haug, G., Weber, H. C., et al. (2019) · Clinical Science · doi:10.1042/cs20181009 · Cited by 49
Controlling Lipid Oxidation via a Biomimetic Iron Chelating Active Packaging Material
Tian, F., Decker, E. A., & Goddard, J. M. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4041832 · Cited by 49
Enzymatic synthesis of catechol and hydroxyl-carboxic acid functionalized chitosan microspheres for iron overload therapy
Brzonova, I., Steiner, W., Zankel, A., Nyanhongo, G. S., & Guebitz, G. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.018 · Cited by 48
New Tris(hydroxypyridinones) as Iron and Aluminium Sequestering Agents: Synthesis, Complexation and In Vivo Studies
Chaves, S., Marques, S. M., Matos, A. M. F., Nunes, A. C. C., Gano, L., Tuccinardi, T., Martinelli, A., & Santos, M. A. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201001335 · Cited by 46
A novel VIVO–pyrimidinone complex: synthesis, solution speciation and human serum protein binding
Gonçalves, G., Tomaz, A. I., Correia, I., Veiros, L. F., Castro, M. M. C. A., Avecilla, F., Palacio, L., Maestro, M. A., Kiss, T., Jakusch, T., et al. (2013) · Dalton Transactions · doi:10.1039/c3dt50553g · Cited by 44
Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer´s disease therapy
Hiremathad, A., Chand, K., Tolayan, L., Rajeshwari, R., Keri, R. S., Esteves, A. R., Cardoso, S. M., Chaves, S., & Santos, M. A. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.11.015 · Cited by 44
Complexation modulated redox behavior of transition metal systems (review)
Rizvi, M. A. (2015) · Russian Journal of General Chemistry · doi:10.1134/s1070363215040337 · Cited by 44
Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties
Nunes, A., Podinovskaia, M., Leite, A., Gameiro, P., Zhou, T., Ma, Y., Kong, X., Schaible, U. E., Hider, R. C., & Rangel, M. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0650-1 · Cited by 41
Self-citation
Reducing power and iron chelating property of Terminalia chebula (Retz.) alleviates iron induced liver toxicity in mice
Sarkar, R., Hazra, B., & Mandal, N. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-144 · Cited by 41
Advancement in the synthesis of metal complexes with special emphasis on Schiff base ligands and their important biological aspects
Singh, P., Yadav, P., Sodhi, K. K., Tomer, A., & Mehta, S. B. (2023) · Results in Chemistry · doi:10.1016/j.rechem.2023.101222 · Cited by 40
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators
Workman, D. G., Tsatsanis, A., Lewis, F. W., Boyle, J. P., Mousadoust, M., Hettiarachchi, N. T., Hunter, M., Peers, C., Tétard, D., & Duce, J. A. (2015) · Metallomics · doi:10.1039/c4mt00326h · Cited by 40
The Fenton Activity of Iron(III) in the Presence of Deferiprone
Ld, D., Neubert, H., & Hider, R. C. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21039 · Cited by 39
Self-citation
Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells
González‐Bártulos, M., Aceves-Luquero, C., Qualai, J., Cussó, O., Martínez, M. Á., de Mattos, S. F., Menéndez, J. A., Villalonga, P., Costas, M., Ribas, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137800 · Cited by 38
Synthesis and Iron(III)-Chelating Properties of Novel 3-Hydroxypyridin-4-one Hexadentate Ligand-Containing Copolymers
Zhou, T., Kong, X. L., Liu, Z. D., Liu, D. Y., & Hider, R. C. (2008) · Biomacromolecules · doi:10.1021/bm701122u · Cited by 37
Self-citation
Chelated iron sources are inhibitors ofPseudomonas aeruginosabiofilms and distribute efficiently in anin vitromodel of drug delivery to the human lung
Musk, D. J., & Hergenrother, P. J. (2008) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.03751.x · Cited by 38
Effect of tris(3-hydroxy-4-pyridinonate) iron(III) complexes on iron uptake and storage in soybean (Glycine max L.)
Santos, C. S., Carvalho, S. M. P., Leite, A., Moniz, T., Roriz, M., Rangel, A. O. S. S., Rangel, M., & Vasconcelos, M. W. (2016) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2016.04.050 · Cited by 37
Enhanced targeting of mitochondrial peroxide defense by the combined use of thiosemicarbazones and inhibitors of thioredoxin reductase
Myers, C. R. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.008 · Cited by 36
Iron chelators as therapeutic iron depletion agents
Birch, N. W., Wang, X., & Chong, H. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.11.1533 · Cited by 36
Different approaches to the study of chelating agents for iron and aluminium overload pathologies
Crisponi, G., Dean, A., Marco, V. D., Lachowicz, J. I., Nurchi, V. M., Remelli, M., & Tapparo, A. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6468-7 · Cited by 35
Redox Properties of the Iron Complexes of Orally Active Iron Chelators CP20, CP502, CP509, and ICL670
Merkofer, M., Kissner, R., Hider, R. C., & Koppenol, W. H. (2004) · Helvetica Chimica Acta · doi:10.1002/hlca.200490272 · Cited by 35
Self-citation
Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: Effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool
Walcourt, A., Kurantsin‐Mills, J., Kwagyan, J., Adenuga, B., Kalinowski, D. S., Lovejoy, D. B., Lane, D. J. R., & Richardson, D. R. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.08.007 · Cited by 34
Tacrine-(hydroxybenzoyl-pyridone) hybrids as potential multifunctional anti-Alzheimer's agents: AChE inhibition, antioxidant activity and metal chelating capacity
Chand, K., Alsoghier, H. M., Chaves, S., & Santos, M. A. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.05.005 · Cited by 33
Tacrine–deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug
Chand, K., Rajeshwari, K., Candeias, E., Cardoso, S. M., Chaves, S., & Santos, M. A. (2018) · Metallomics · doi:10.1039/c8mt00143j · Cited by 33
Beneficial effects of quercetin–iron complexes on serum and tissue lipids and redox status in obese rats
Imessaoudene, A., Merzouk, H., Berroukeche, F., Mokhtari-Soulimane, N. A., Bensenane, B., Cherrak, A., Merzouk, S. A., & Elhabiri, M. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.11.011 · Cited by 34
Biomimetic design of chelating interfaces
Tian, F., Roman, M. J., Decker, E. A., & Goddard, J. M. (2014) · Journal of Applied Polymer Science · doi:10.1002/app.41231 · Cited by 32
Sigma donor and pi acceptor characteristics of certain NN-bidentate ligands: a DFT Study
Maqsood, S. R., Islam, N., Bashir, S., Khan, B., & Pandith, A. H. (2013) · Journal of Coordination Chemistry · doi:10.1080/00958972.2013.800866 · Cited by 32
A DFT study on the complex formation between desferrithiocin and metal ions (Mg2+, Al3+, Ca2+, Mn2+, Fe3+, Co2+, Ni2+, Cu2+, Zn2+)
Kaviani, S., Izadyar, M., & Housaindokht, M. R. (2017) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2016.12.012 · Cited by 32
Design of Iron chelators: Syntheses and iron (III) complexing abilities of tripodal tris-bidentate ligands
d′Hardemare, A. D. M., Torelli, S., Serratrice, G., & Pierre, J. (2006) · BioMetals · doi:10.1007/s10534-005-2997-2 · Cited by 32
The interaction of phenolic acids with Fe(III) in the presence of citrate as studied by isothermal titration calorimetry
Yang, S., Bai, G., Chen, L., Shen, Q., Diao, X., & Zhao, G. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.02.052 · Cited by 32
Synthesis and characterization of new β-diketo derivatives with iron chelating ability
Benassi, R., Ferrari, É., Grandi, R., Lazzari, S., & Saladini, M. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.09.020 · Cited by 31
Bis(hydroxyamino)triazines: versatile and high-affinity tridentate hydroxylamine ligands for selective iron( iii ) chelation
Ekeltchik, I., Gun, J., Lev, O. E., Shelkov, R., & Melman, A. (2005) · Dalton Transactions · doi:10.1039/b513719e · Cited by 31
Synthesis and Iron Sequestration Equilibria of Novel Exocyclic 3-Hydroxy-2-pyridinone Donor Group Siderophore Mimics
Harrington, J. M., Chittamuru, S., Dhungana, S., Jacobs, H. K., Gopalan, A. S., & Crumbliss, A. L. (2010) · Inorganic Chemistry · doi:10.1021/ic902595c · Cited by 30
3-Hydroxypyridinone Derivatives as Metal-Sequestering Agents for Therapeutic Use
Santos, M. A., & Chaves, S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.162 · Cited by 29
Redox activation of Fe(III)–thiosemicarbazones and Fe(III)–bleomycin by thioredoxin reductase: specificity of enzymatic redox centers and analysis of reactive species formation by ESR spin trapping
Myers, J. M., Cheng, Q., Antholine, W. E., Kalyanaraman, B., Filipovska, A., Arnér, E. S. J., & Myers, C. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.016 · Cited by 30
Ferric Complexes of 3-Hydroxy-4-pyridinones Characterized by Density Functional Theory and Raman and UV–vis Spectroscopies
Šebestı́k, J., Šafařík, M., & Bouř, P. (2012) · Inorganic Chemistry · doi:10.1021/ic202004d · Cited by 30
Unexpected formation of a copper( ii ) 12-metallacrown-4 with (S)-glutamic-γ-hydroxamic acid: a thermodynamic and spectroscopic study in aqueous solution
Tegoni, M., Dallavalle, F., Belosi, B., & Remelli, M. (2004) · Dalton Transactions · doi:10.1039/b316607d · Cited by 29

Authors: Liu, Z. D., & Hider, R. C.
Affiliations: King's College London (GB)
Corresponding author: Hider, Robert C
ORCID: Hider, Robert C
Venue: Coordination Chemistry Reviews
Publisher: Elsevier BV
Published: 2002-10
Volume: 232
Issue: 1-2
Pages: 151-171
ISSN: 0010-8545 (ISSN-L)
DOI: 10.1016/s0010-8545(02)00050-4
OpenAlex: W1990645562
Cited by: 287
References: 132
Citations by year: 2026: 7 · 2025: 10 · 2024: 9 · 2023: 7 · 2022: 10 · 2021: 6 · 2020: 12 · 2019: 10 · 2018: 10 · 2017: 14 · 2016: 13 · 2015: 21 · 2014: 12 · 2013: 24 · 2012: 13
FWCI: 5.68
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Coordination Chemistry Reviews (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
Physical Sciences › Chemistry › Inorganic Chemistry › Inorganic and Organometallic Chemistry
Keywords: iron chelators, iron overload, desferrioxamine B, oral bioavailability, metal ion selectivity, iron(III) complexes, hydroxamate, hydroxypyridinone, triazoles, ligand design, toxicity, bioavailability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Design of iron chelators with therapeutic application

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks